WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

As a reminder, Acadia Pharmaceuticals has two primary products on the market. The first is Nuplazid, which was approved in ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.

With increasing pharmaceutical production and a growing focus on patient safety, the demand for specialized and customizable ...

On Friday, Recursion Pharmaceuticals Inc (RXRX) stock saw a modest uptick, ending the day at $7.1 which represents a slight increase of $0.17 or 2.45% from the prior close of $6.93. The stock opened ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) is scheduled to announce Q3 earnings results on Tuesday, November 12th, after market ...

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

The Nifty Pharma index closed 0.88 per cent at 22344.25. Benchmark NSE Nifty50 index ended down 6.91 points at 24141.3, while ...

The government's new Rs 500 crore scheme for the medical device industry will not only boost domestic manufacturing but also ...